Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/03/2892187/10564/en/Cyclacel-Pharmaceuticals-Reports-New-Clinical-Data-at-2024-ASCO-Annual-Meeting-Highlighting-Oral-Fadraciclib-s-Potential-as-a-Precision-Medicine-for-Cancer.html
https://www.globenewswire.com/news-release/2024/05/14/2881880/10564/en/Cyclacel-Pharmaceuticals-Reports-First-Quarter-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/05/08/2877901/10564/en/Cyclacel-Pharmaceuticals-to-Release-First-Quarter-2024-Financial-Results.html
https://www.globenewswire.com/news-release/2024/05/02/2874767/10564/en/Cyclacel-Pharmaceuticals-Announces-Closing-of-8-0-Million-Private-Placement-Priced-At-The-Market-Under-NASDAQ-Rules.html
https://www.globenewswire.com/news-release/2024/04/30/2872037/10564/en/Cyclacel-Pharmaceuticals-Announces-8-0-Million-Private-Placement-Priced-At-The-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com/news-release/2024/04/01/2855230/10564/en/Cyclacel-Pharmaceuticals-to-Present-New-Clinical-Data-at-2024-ASCO-Annual-Meeting-Highlighting-Fadraciclib-s-Potential-as-a-Precision-Medicine-for-Cancer.html
https://www.globenewswire.com/news-release/2024/03/19/2848964/10564/en/Cyclacel-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results-and-Provides-Business-Update.html
https://www.globenewswire.com/news-release/2024/01/30/2820102/10564/en/Cyclacel-Pharmaceuticals-Announces-the-Appointment-of-Brian-Schwartz-M-D-as-Chief-Medical-Officer.html
https://www.globenewswire.com/news-release/2023/12/22/2800620/10564/en/Cyclacel-Pharmaceuticals-Announces-Registered-Direct-and-Private-Placement-Offering-Priced-At-The-Market-Under-Nasdaq-Rules.html
https://www.globenewswire.com//news-release/2023/12/18/2797893/10564/en/Cyclacel-Pharmaceuticals-Reports-Fadraciclib-Phase-1-Data-Suggesting-Efficacy-Against-Tumors-With-CDKN2A-CDKN2B-and-MTAP-Deletions.html